278 related articles for article (PubMed ID: 12775195)
1. Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?
Zesiewicz TA; Hauser RA
CNS Drugs; 2003; 17(8):593-600. PubMed ID: 12775195
[TBL] [Abstract][Full Text] [Related]
2. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?
Chaudhuri KR; Pal S; Brefel-Courbon C
Drug Saf; 2002; 25(7):473-83. PubMed ID: 12093305
[TBL] [Abstract][Full Text] [Related]
3. Dopamine agonists and sleep in Parkinson's disease.
Cantor CR; Stern MB
Neurology; 2002 Feb; 58(4 Suppl 1):S71-8. PubMed ID: 11909988
[TBL] [Abstract][Full Text] [Related]
4. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U
Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
[TBL] [Abstract][Full Text] [Related]
5. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
Del Dotto P; Gambaccini G; Caneparo D; Berti C; Bernardini S; Bonuccelli U
Neurol Sci; 2003 Oct; 24(3):170-1. PubMed ID: 14598071
[TBL] [Abstract][Full Text] [Related]
6. Excessive daytime sleepiness in patients with Parkinson's disease.
Knie B; Mitra MT; Logishetty K; Chaudhuri KR
CNS Drugs; 2011 Mar; 25(3):203-12. PubMed ID: 21323392
[TBL] [Abstract][Full Text] [Related]
7. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.
Hobson DE; Lang AE; Martin WR; Razmy A; Rivest J; Fleming J
JAMA; 2002 Jan 23-30; 287(4):455-63. PubMed ID: 11798367
[TBL] [Abstract][Full Text] [Related]
8. Sleep attacks in Parkinson's disease.
Pirker W; Happe S
Lancet; 2000 Aug; 356(9229):597-8. PubMed ID: 10950264
[No Abstract] [Full Text] [Related]
9. Motor vehicle accidents in Parkinson's disease: A questionnaire study.
Ueno T; Kon T; Haga R; Nishijima H; Tomiyama M
Acta Neurol Scand; 2018 Feb; 137(2):218-223. PubMed ID: 28948617
[TBL] [Abstract][Full Text] [Related]
10. Sleep disorders in Parkinson's disease.
Thorpy MJ
Clin Cornerstone; 2004; 6 Suppl 1A():S7-15. PubMed ID: 15259535
[TBL] [Abstract][Full Text] [Related]
11. Piribedil-induced sleep attacks in Parkinson's disease.
Tan EK
Fundam Clin Pharmacol; 2003 Feb; 17(1):117-9. PubMed ID: 12588638
[TBL] [Abstract][Full Text] [Related]
12. Daytime sleepiness and other sleep disorders in Parkinson's disease.
Homann CN; Forstner M; Ivanic G; Ott E
Neurology; 2002 Jun; 58(12):1863; author reply 1863-4. PubMed ID: 12084897
[No Abstract] [Full Text] [Related]
13. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
Liguori C; Mercuri NB; Albanese M; Olivola E; Stefani A; Pierantozzi M
J Neurol; 2019 Mar; 266(3):636-641. PubMed ID: 30607535
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.
Rodrigues TM; Castro Caldas A; Ferreira JJ
Parkinsonism Relat Disord; 2016 Jun; 27():25-34. PubMed ID: 27010071
[TBL] [Abstract][Full Text] [Related]
15. Sleep attacks may not be a side effect of dopaminergic medication.
Homann CN; Homann B; Ott E; Park KB
Mov Disord; 2003 Dec; 18(12):1569-70; author reply 1571. PubMed ID: 14673904
[No Abstract] [Full Text] [Related]
16. Excessive daytime sleepiness in Parkinson's disease.
Schapira AH
Neurology; 2004 Oct; 63(8 Suppl 3):S24-7. PubMed ID: 15505139
[No Abstract] [Full Text] [Related]
17. Sleep disorders in patients with Parkinson's disease: epidemiology and management.
Larsen JP; Tandberg E
CNS Drugs; 2001; 15(4):267-75. PubMed ID: 11463132
[TBL] [Abstract][Full Text] [Related]
18. Excessive daytime sleepiness in parkinsonism.
Arnulf I
Sleep Med Rev; 2005 Jun; 9(3):185-200. PubMed ID: 15893249
[TBL] [Abstract][Full Text] [Related]
19. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
Gjerstad MD; Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
Neurology; 2006 Sep; 67(5):853-8. PubMed ID: 16966550
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Etminan M; Samii A; Takkouche B; Rochon PA
Drug Saf; 2001; 24(11):863-8. PubMed ID: 11665873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
